Nasal Spray to aid SAD, The Benefits of CRAACO, and more

In this ISSUE

FDA Moves to Modernize Drug Review Process

Fundamental Changes Required to Realize Benefits of CRAACO

Proscia Launches Commercial Research Edition of Digital Pathology Platform

Therapeutic Specific Areas

Nasal Spray Research Moves to Social Anxiety Disorder

Dr. Mark Smith, Chief Medical Officer of VistaGen Therapeutics, sits down with Moe Alsumidaie to discuss the challenges of modern psychiatric clinical trial design and implementation and their neuroactive pherine, PH94B.
... /Read more/

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
North America: Thursday, June 13, 2019 at 11am EDT | 10am CDT | 8am PDT

Clinical Trial News

Latest in Business and People News

The latest happenings in Clinical Trials. Find out who's been promoted, appointed, and much more.
... /Read more/

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
Europe: Thursday, June 6, 2019 at 3pm BST | 4pm CEST

Calendar

/ 4^th Annual Managed Access Programmes and Accelerated Pathways 5/21–5/22 /

/ BIO International Convention 6/3-6/6 /

/ 8^th Annual Publication and Clinical Trial Transparency Europe – 6/11-6/12 /

/ Rare Disease Innovation and Partnering Summit – 6/13-/14 /

/ DIA 2019 Global Annual Meeting – 6/23-6/27 /

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
Wednesday, May 15, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Standardization Drives Transparency and Optimization of Contract/Budget Processes in Clinical Trial Startup
On Demand

Learn More

Nonadherence

Understanding the Statistical Implications of Undetected Risk

Nonadherence in clinical trials plays a significant role in influencing the quality of data, trial results and, subsequently trial cost and duration. It may stem from unintentional drivers, such as forgetfulness, poor organizational skills, protocol regimen complexity, or experiencing an Adverse Event.
... /Read more/

Refocusing on Risk Mitigation in Starting Clinical Trials
Tuesday, May 28, 2019 at 1pm EDT | 12pm CDT | 10am PDT

Risk Based Monitoring

A Roadmap for Implementing Risk-Based Monitoring and Quality Management

Integrating a systemic risk management strategy for identifying clinical trial risks–and the importance of applying change management techniques throughout the preparation, planning, and execution stages.
... /Read more/

A new way to assess changes in trial complexity, success and duration: The Clinical Development Productivity Index
Tuesday, May 21, 2019 at 11am EDT

Weaponizing Cancer as a European Election Pledge

Peter O'Donnell writes about Manfred Weber's announcement of what he called "his European Master Plan against Cancer" – with what he termed "a guarantee" for European citizens, taking political lobbying over health to a new level in Europe
... /Read more/

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
Tuesday, May 21, 2019 at 2:30pm IST | 5pm CST | 6pm JST

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

Technology: Friend vs Foe - Considerations for Practical Execution of a Risk-Based Monitoring Strategy
On Demand

Learn more

website / blog / advertise / subscribe